These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3768244)

  • 1. Pharmacokinetics of intravenously administered haem arginate.
    Tokola O; Tenhunen R; Volin L; Mustajoki P
    Br J Clin Pharmacol; 1986 Sep; 22(3):331-5. PubMed ID: 3768244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haem arginate improves hepatic oxidative metabolism in variegate porphyria.
    Tokola O; Mustajoki P; Himberg JJ
    Br J Clin Pharmacol; 1988 Dec; 26(6):753-7. PubMed ID: 3242580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of haem arginate in acute hepatic porphyria.
    Herrick AL; McColl KE; Moore MR; Cook A; Goldberg A
    Lancet; 1989 Jun; 1(8650):1295-7. PubMed ID: 2566827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of haem after parenteral administration of haem arginate to rabbits.
    Lindén IB; Tokola O; Karlsson M; Tenhunen R
    J Pharm Pharmacol; 1987 Feb; 39(2):96-102. PubMed ID: 2882011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects.
    Doberer D; Haschemi A; Andreas M; Zapf TC; Clive B; Jeitler M; Heinzl H; Wagner O; Wolzt M; Bilban M
    Br J Pharmacol; 2010 Dec; 161(8):1751-62. PubMed ID: 20718734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haem arginate: a new stable haem compound.
    Tenhunen R; Tokola O; Lindén IB
    J Pharm Pharmacol; 1987 Oct; 39(10):780-6. PubMed ID: 2891815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barbiturate and ethanol sleeping times and pharmacokinetics of propranolol in mice after intravenous administration of haem arginate.
    Tokola O
    Pharmacol Toxicol; 1987 Jan; 60(1):51-3. PubMed ID: 3562390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of haem arginate on variegate porphyria.
    Timonen K; Mustajoki P; Tenhunen R; Lauharanta J
    Br J Dermatol; 1990 Sep; 123(3):381-7. PubMed ID: 2206975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular and metabolic effects of the haem oxygenase-1 inducer haem arginate in subjects with the metabolic syndrome: A translational cross-over study.
    Dekker D; Dorresteijn MJ; Peters WH; Bilos A; Pennings SW; Wagener FA; Smits P
    Diab Vasc Dis Res; 2016 Jan; 13(1):41-8. PubMed ID: 26468161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats.
    Tokola O; Lindén IB; Tenhunen R
    Pharmacol Toxicol; 1987 Jul; 61(1):75-8. PubMed ID: 3628186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated intravenous administration of haem arginate upon hepatic metabolism of foreign compounds in rats and dogs.
    Tokola O
    Br J Pharmacol; 1987 Apr; 90(4):661-8. PubMed ID: 3580703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma clearance of 125I-labelled haemopexin in normal and haem-loaded rabbits.
    Lane RS; Rangeley DM; Liem HH; Wormsley S; Muller-Eberhard U
    Br J Haematol; 1973 Oct; 25(4):533-40. PubMed ID: 4127614
    [No Abstract]   [Full Text] [Related]  

  • 13. Haem arginate as a treatment for myelodysplastic syndromes.
    Ruutu T; Volin L; Tenhunen R
    Br J Haematol; 1987 Apr; 65(4):425-8. PubMed ID: 3580298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein.
    Smith A; Morgan WT
    Biochem J; 1979 Jul; 182(1):47-54. PubMed ID: 496916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heme arginate: effects on hemostasis.
    Volin L; Rasi V; Vahtera E; Tenhunen R
    Blood; 1988 Mar; 71(3):625-8. PubMed ID: 3345341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
    Sardh E; Rejkjaer L; Andersson DE; Harper P
    Clin Pharmacokinet; 2007; 46(4):335-49. PubMed ID: 17375984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of heme arginate for acute porphyric attacks.
    Mustajoki P; Nordmann Y
    Arch Intern Med; 1993 Sep; 153(17):2004-8. PubMed ID: 8357285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization in patients with hypersensitivity to haem arginate: A case report.
    Chapman E; Leal D; Matijasevic E; García E
    World Allergy Organ J; 2019; 12(1):100002. PubMed ID: 30937127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL; Healey JF; Lourie AN; Gerron GG
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan pyrrolase, the regulatory free haem and hepatic porphyrias. Early depletion of haem by clinical and experimental exacerbators of porphyria.
    Badawy AA
    Biochem J; 1978 Jun; 172(3):487-94. PubMed ID: 687356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.